MedPath

A Clinical trial of â??NAGA CHENDOORAMâ?? (herbomineral formulation) in management of Karapatha soolai (Diabetic peripheral Neuropathy)

Phase 2
Conditions
Health Condition 1: null- Diabetic peripheral Neuropathy
Registration Number
CTRI/2015/01/005347
Lead Sponsor
R Ramya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

PATIENTS WHO HAVE DIAGNOSED AS NIDDM with peripheral neuropathy symptoms

Exclusion Criteria

IDDM

PREGNANCY AND LACTATION

NEUROPATHY CAUSED BY ANYTHING OTHER THAN DIABETES

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
therapeutic efficacy of the trial drug in the patientsTimepoint: 50 days
Secondary Outcome Measures
NameTimeMethod
establishment of safety and accuracy of the trial drugTimepoint: 50 days
© Copyright 2025. All Rights Reserved by MedPath